Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.45 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 8/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | NCOA2 | Q15596 | 2/20 | 0.40 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18785100 | 1.00 | ALDH1A1 (0.47) | ALDH1A1NPSR1TSHRMAPK1KCNQ3 | |
| SCHEMBL15849845 | 1.00 | ALDH1A1 (0.47) | ALDH1A1NPSR1TSHRMAPK1KCNQ3 | |
| SCHEMBL30132089 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| SCHEMBL432548 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| SCHEMBL13458992 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| SCHEMBL7915441 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| SCHEMBL14599149 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| SCHEMBL63297 | 0.94 | MAPT (0.48) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| Hydrogen Peroxide SCHEMBL5566292 | 0.92 | MAPT (0.47) | ALDH1A1NPSR1TSHRMAPK1MAPT | |
| Ammonia Solution, Strong SCHEMBL2319900 | 0.92 | MAPT (0.47) | ALDH1A1NPSR1TSHRMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4722893-A | Reagents for enzyme immunoassay for apolipoprotein B | SHIRAIMATSU SHINYAKU KABUSHIKI KAISHA (JP) | 1988-02-02 | — | — | US | claimed |
| US-10036098-B2 | Method for determining an analyte content of a liquid sample by means of a bioanalyzer | ENDRESS+HAUSER CONDUCTA GMBH+CO. KG (DE) | 2018-07-31 | — | — | US | disclosed |
| EP-2310403-B1 | NEW BACTERIOPHAGE ADHESION PROTEINS | BIOMÉRIEUX S A (FR) | 2017-12-06 | — | — | EP | disclosed |
| US-20170072069-A1 | BIOACTIVE AGENTS UNDER WATER DISPERSIBLE SOLID FORMS FOR FOOD, NUTRACEUTICAL, AGRICULTURAL AND PHARMACEUTICAL APPLICATIONS | B-ORGANIC FILMS CORP. (CA) | 2017-03-16 | — | — | US | disclosed |
| EP-3124492-A1 | NEW BACTERIOPHAGE ADHESION PROTEINS | bioMérieux S.A. (FR) | 2017-02-01 | — | — | EP | disclosed |
| EP-2721150-B1 | POLYHEDRAL CAGE-CONTAINING MESOPOROUS METAL-ORGANIC FRAMEWORKS AS PLATFORM FOR BIOCATALYSIS, METHODS OF MAKING THESE FRAMEWORKS, AND METHODS OF USING THESE FRAMEWORKS | UNIV SOUTH FLORIDA (US) | 2016-12-07 | — | — | EP | disclosed |
| US-9404105-B2 | Polyhedral cage-containing mesoporous metal-organic frameworks as platform for biocatalysis, methods of making these frameworks, and methods of using these frameworks | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-08-02 | — | — | US | disclosed |
| US-9394534-B2 | Method and means for enrichment, removal and detection of gram-positive bacteria | BIOMERIEUX S.A. (FR) | 2016-07-19 | — | — | US | disclosed |
| EP-2601291-B1 | A NOVEL GLUCOSE OXIDASE | BRAIN BIOTECHNOLOGY RES & INFORMATION NETWORK AG (DE) | 2015-11-25 | — | — | EP | disclosed |
| US-20150087044-A1 | POLYHEDRAL CAGE-CONTAINING MESOPOROUS METAL-ORGANIC FRAMEWORKS AS PLATFORM FOR BIOCATALYSIS, METHODS OF MAKING THESE FRAMEWORKS, AND METHODS OF USING THESE FRAMEWORKS | UNIVERSITY OF SOUTH FLORIDA | 2015-03-26 | — | — | US | disclosed |
| US-5824474-A | Method for detecting nucleic acid | FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-10-20 | — | — | US | disclosed |
| EP-0453055-B1 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | DIMMINACO AG SA LTD (CH) | 1997-09-03 | — | — | EP | disclosed |
| EP-0725149-A1 | METHOD OF DETECTING NUCLEIC ACID | FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) | 1996-08-07 | — | — | EP | disclosed |
| EP-0453054-B1 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (BE) | 1996-07-03 | — | — | EP | disclosed |
| EP-0453054-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (Société Anonyme) (BE) | 1991-10-23 | — | — | EP | disclosed |
| EP-0453055-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (Société Anonyme) (BE) | 1991-10-23 | — | — | EP | disclosed |
| EP-0155141-B1 | STANDARD MATERIALS FOR MEASUREMENT OF IMMUNE COMPLEXES AND METHOD FOR MEASUREMENT OF IMMUNE COMPLEXES | TEIJIN LIMITED (JP) | 1990-12-05 | — | — | EP | disclosed |
| US-4945039-A | Standard materials for measurement of immune complexes and method for measurement of immune complexes | TEIJIN LIMITED (JP) | 1990-07-31 | — | — | US | disclosed |
| US-4722893-A | Reagents for enzyme immunoassay for apolipoprotein B | SHIRAIMATSU SHINYAKU KABUSHIKI KAISHA (JP) | 1988-02-02 | — | — | US | disclosed |
| EP-0155141-A2 | Standard materials for measurement of immune complexes and method for measurement of immune complexes | TEIJIN LIMITED (JP) | 1985-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170072069-A1 | BIOACTIVE AGENTS UNDER WATER DISPERSIBLE SOLID FORMS FOR FOOD, NUTRACEUTICAL, AGRICULTURAL AND PHARMACEUTICAL APPLICATIONS | GYS2, GHDC, SFPQ | ALDH1A1 4351/4885NPSR1 3456/4885TSHR 4728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.